Cleerly launches updated heart disease software

Cleerly has launched Cleerly 2.2.0, a new version of its software that includes user experience improvements and three new tools.

By AuntMinnie.com staff writers
February 9, 2022

The new version features a quantitative comparison tool that tracks heart disease by the amount and type of atherosclerosis. The new technology also calculates the percentage of atheroma volume, enabling the quantification of the percentage of the vessel that is full of plaque. 

See full article HERE.

Cardiovascular Blind Spots and How Cleerly Is Changing the Game

Cardiovascular Blind Spots and How Cleerly Is Changing the Game

In The Future of Medicine Podcast, Aaron Wenzel, MD, and Jennifer Justus, MSN, APRN, FNP-C dive into how Cleerly has revolutionized their ability to...

Read More
AI Leading the Way to More Precise Diagnostics and Disease Risk Prediction

AI Leading the Way to More Precise Diagnostics and Disease Risk Prediction

Inside Precision Medicine features our Chief Scientific Officer, Dr. Udo Hoffmann, on how AI has changed CT imaging and the TRANSFORM trial that may...

Read More
Digital Health 50: The Most Promising Digital Health Companies of 2023

Digital Health 50: The Most Promising Digital Health Companies of 2023

Selected from more than 10,000 private healthcare companies, Cleerly is named one of CB Insight’s Digital Health 50 based on R&D, Mosaic scores,...

Read More
CNBC Highlights Cleerly's Mission to Outsmart America's No. 1 Killer

CNBC Highlights Cleerly's Mission to Outsmart America's No. 1 Killer

CNBC interviews Cleerly CEO, James Min, MD, on how Cleerly aims to improve personalized cardiac care and create a world without heart attacks. Read...

Read More
MedTech Strategist: Cleerly’s Personalized Approach to Heart Attack Risk

MedTech Strategist: Cleerly’s Personalized Approach to Heart Attack Risk

In this interview, Cleerly Founder and CEO, James Min, MD, shares how despite advances in cardiology, most heart attacks occur without warning....

Read More

Cleerly's AI scans comparable to gold-standard angiography

Only a few months after it emerged from stealth and burst onto the medtech scene, Cleerly is already living up to its name.

Read More